Novo Nordisk A/S' Q1 earnings reveal strong growth in semaglutide-driven sales despite a slight revenue miss. Learn more ...

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

The FDA will decide whether to approve a once-daily, 25 mg oral formulation of semaglutide (Wegovy) by the end of 2025. If ...

Novo Nordisk and a popular virtual health company are making Wegovy more accessible to millions of more Americans. Hims & ...

Outsourcing facilities can continue to compound semaglutide injectable drugs until May 22, after which date the FDA may take ...

Empower describes itself as the nation’s largest compounding pharmacy — a type ... There have been reports of dosing errors associated with compounded semaglutide products, and some medical ...

While there is not currently a shortage of Ozempic, previous difficulties in supplying this medication have led to some pharmacies offering compounded semaglutide. The Food and Drug Administration ...

As the popularity of peptides continues to rise in 2025, fueled by the success of GLP-1 medications like Semaglutide and Tirzepatide ... ensuring proper dosing and pharmaceutical-grade quality.

A standard dose of semaglutide is 2.4mg, but we start patients on much lower doses (0.25mg) and gradually build up to this by increasing the dose each month. This is because starting at the full ...

Costs start from $260 per month and increase from there. Availability: A standard dose of semaglutide is 2.4mg, but we start patients on much lower doses (0.25mg) and gradually build up to this by ...